MustGrow Closes $2.0 Million Non-Brokered LIFE Offering

Executive Summary

• MustGrow Biologics Corp. closed a non‑brokered private placement of 4,000,000 units at $0.50 per unit, generating gross proceeds of $2,000,000.
• Each unit includes one common share and one warrant exercisable for 60 months at an exercise price of $0.70 per share.
• Net proceeds are earmarked for inventory production of the TerraSante™ mustard‑derived biofertility product, additional agricultural inventory for NexusBioAg distribution, and general working capital.

Key Details

• Offering Size & Price: 4,000,000 units @ $0.50 per unit → $2,000,000 gross proceeds.
• Unit Composition:
• 1 common share of MustGrow.
• 1 common share purchase warrant (exercisable for 60 months at $0.70).
• Warrant Terms: Each whole warrant allows the holder to purchase one additional share at $0.70; exercisable for a period of 60 months from closing.
• Use of Proceeds:
• Inventory production for TerraSante™ (mustard‑derived organic biofertility product).
• Inventory for agricultural products sold via NexusBioAg platform.
• Working capital and general corporate purposes.
• Exemption & Regulatory Details: Offering relied on the listed issuer financing exemption under NI 45‑106 (Part 5A) as modified by Coordinated Blanket Order 45‑935; no hold period for Canadian resident subscribers per TSXV rules.
• Finder Compensation:
• Cash fee of $105,000 (6.0% of gross proceeds) paid to eligible finders.
• Issuance of 210,000 non‑transferable Finder Warrants (representing 6.0% of the shares in the units), each exercisable at $0.70 for 60 months; subject to a statutory hold period of four months and one day.
• TSXV Approval: The LIFE Offering remains subject to final approval by the TSX Venture Exchange.

Notable Quotes

(No direct quotes were provided in the release.)